Blog

About those Generic Drugs

Everyone likes generic drugs.  So do I.  Who wants to pay those shocking prices–you know, a couple bucks or even a few bucks a pill for…

Blog

Regulation killed the GMO star

This is an amazing story of science success, and of consumer loss. Phillip Larkin got funding from Tasmanian Alkaloids to create a more potent poppy…

Blog

Death & Taxes 2008

If you think that picking up the phone book sized federal budget is a bit daunting, you might want to get the graphic version.

Blog

Bad teeth (2)

Eli— Here’s another theory — fluoridation of water is very widespread in the U.S. but is very limited in England. (About 10 percent of…

Blog

Re: X-Prize – and yet another

Fran’s post raises an important point about trade-offs and the ossifying effects of mandates (why on earth don’t we have a much better system…

Blog

The Nonpartisan Regulatory State

To believe Democratic politicians, the U.S. has entered an era of near-laissez faire economics.  Regulatory agencies have faded away.  Uncle Sam has gone on vacation. …

Blog

Biotechnology Spin-Zone

The suppliers, producers, and retailers in the industrial organic food chain have long lamented about the possibility of grains from plants bred with molecular plant…

Blog

Irreligious Fervor

The politically-correct National Fair Housing Alliance (NFHA) has brought a disturbing lawsuit against an insurance company for an product aimed at church-goers, which provides…

Blog

Big drop in commodity prices

Commodity prices plunge is the big news in the markets today. According to Bloomberg today, commodities are– . . . heading for the biggest…

Blog

Defending Liberty in India

CEI’s friends at the Liberty Institute in New Delhi have launched a new website, InDefenceofLiberty.org. Of particular interest to openmarket readers might be the…